XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.
C
C

Carmax


Berita

U.S. STOCKS IonQ, Cassava Sciences, MeridianLink

BUZZ-U.S. STOCKS ON THE MOVE-IonQ, Cassava Sciences, MeridianLink Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The blue-chip Dow rose on Friday to hit an intraday record and small-cap stocks outperformed after a benign inflation report cleared the way for the Federal Reserve to focus on shoring up the labor market while continuing its interest rate easing.
C
E
R
S
R
W
U
U
G
C
L

U.S. STOCKS Regeneron, HP Inc, Honeywell International

BUZZ-U.S. STOCKS ON THE MOVE-Regeneron, HP Inc, Honeywell International Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The blue-chip Dow rose on Friday to hit an intraday record high and small-cap stocks outperformed after a benign inflation report cleared the way for the Federal Reserve to focus on shoring up the labor market while continuing its interest rate easing.
A
C
E
L
R
S
W
W
U
U
D
C
L

U.S. STOCKS Cassava Sciences, Wave Life Sciences, Bumble

BUZZ-U.S. STOCKS ON THE MOVE-Cassava Sciences, Wave Life Sciences, Bumble Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set for a marginally higher open on Friday after data underscored the narrative that price pressures were cooling, raising expectations that the Federal Reserve's next move might be another outsized interest rate cut.
A
C
S
U
C

U.S. STOCKS Bumble, Cassava Sciences, IonQ

BUZZ-U.S. STOCKS ON THE MOVE-Bumble, Cassava Sciences, IonQ Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures inched lower on Friday, as investors refrained from placing big bets ahead of a crucial inflation r
A
C
S
U
C

Brokerages raise Carmax PT on expectations of recovery in US used car market

BUZZ-Brokerages raise Carmax PT on expectations of recovery in US used car market ** Needham raises target price for used car retailer CarMax KMX.N to $90 from $87; a 15% upside to the stock's last close ** Says co is well positioned for a cyclical recovery in U.S. market given industry leadership; maintains "Buy" rating ** RBC Capital Markets rais
C

U.S. Albemarle, Nasdaq, Salesforce

U.S. RESEARCH ROUNDUP-Albemarle, Nasdaq, Salesforce Sept 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Albemarle, Nasdaq and Salesforce, on Friday. HIGHLIGHTS * Agios Pharmaceuticals Inc AGIO.O : Leerink Partners cuts to market perform from outperform * Albemarle ALB.N : Jefferies cuts target price to $120 from $124 * Dollar General Corp DG.N : Citigroup cuts to sell from neutral * Nasdaq Inc NDAQ.O : RBC initia
A
C
C
C
D
E
N
P
S
T
D
A
C
C
U

U.S. STOCKS Starbucks, Crocs, Accenture

BUZZ-U.S. STOCKS ON THE MOVE-Starbucks, Crocs, Accenture Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes rose in choppy trading on Thursday, with the S&P 500 hitting an intraday record high after Micron's upbeat forecast rekindledthe hype around artificial intelligence, and a soft jobless claims report soothed worries about the labor market.
C
C
H
I
J
L
M
N
N
Q
S
A
U
U
A
C

CarMax beats second-quarter revenue estimates on higher unit sales

UPDATE 1-CarMax beats second-quarter revenue estimates on higher unit sales Recasts lede, updates shares, adds details from press release and analyst comments in paragraphs 4-9 By Ananta Agarwal Sept 26 (Reuters) - Used car retailer CarMax KMX.N beat Wall Street estimates for second-quarter revenue on Thursday as price cuts on used vehicles boosted unit sales, especially in the retail segment, sending its shares up 6.4% in afternoon trading.
C

U.S. STOCKS Crocs, First Solar, Qualcomm

BUZZ-U.S. STOCKS ON THE MOVE-Crocs, First Solar, Qualcomm Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes rose on Thursday, with the S&P 500 hitting a record high, as Micron's upbeat forecast revived the frenzy around artificial intelligence, and a softer-than-expected jobless claims report soothed worries about the labor market.
B
C
H
I
L
M
N
N
Q
S
U
U
C

U.S. STOCKS ASML Holding, Meta, Crocs

BUZZ-U.S. STOCKS ON THE MOVE-ASML Holding, Meta, Crocs Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were set to open higher on Thursday as Micron's upbeat forecast revived the frenzy around artificial intelligence, while investors assessed a labor market report and awaited comments from Federal Reserve Chair Jerome Powell.
C
M
M
N
Q
S
A
U
E
R
C

CarMax misses quarterly profit estimates as average price per vehicle dips

CarMax misses quarterly profit estimates as average price per vehicle dips Sept 26 (Reuters) - Used car retailer CarMax KMX.N missed Wall Street estimates for second-quarter profit on Thursday as price cuts on used vehicles boosted unit sales but kept margins depressed. Shares of the company were down 7.6% in premarket trading. Pre-owned vehicle retailers have had a bumpy ride, with profitability worsening over the last few years as new vehicle availability improved.
C

CarMax down after missing Q2 profit estimates

BUZZ-CarMax down after missing Q2 profit estimates ** Used car retailer CarMax's KMX.N shares fall 8.7% to $68 premarket ** Company posts Q2 EPS of 85 cents vs analysts' average estimate of 86 cents - LSEG data ** Average selling price per vehicle down 4.6% and 12.9% in used and wholesale units, respectively ** Overall revenue at $7.01 bln, down ~1
C

U.S. STOCKS Accenture, Starbucks, Southwest Airlines

BUZZ-U.S. STOCKS ON THE MOVE-Accenture, Starbucks, Southwest Airlines Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures climbed on Thursday after Micron's upbeat forecast revived the euphoria around artificial intelligence on Wall Street, while investors also awaited economic data and remarks from Federal Reserve Chair Jerome Powell.
A
C
M
M
N
Q
S
A
U
E
T
C

Carmax Reports Second Quarter Fiscal Year 2025 Results

BRIEF-Carmax Reports Second Quarter Fiscal Year 2025 Results Sept 26 (Reuters) - Carmax Inc KMX.N : CARMAX REPORTS SECOND QUARTER FISCAL YEAR 2025 RESULTS CARMAX: QTRLY RETAIL USED UNIT SALES INCREASED 5.1% & COMPARABLE STORE USED UNIT SALES INCREASED 4.3% FROM PRIOR YEAR'S Q2 CARMAX INC: QTRLY COMBINED RETAIL & WHOLESALE USED VEHICLE UNIT SALES WE
C

Carmax Q2 EPS USD 0.85 Vs. IBES Estimate USD 0.86

BRIEF-Carmax Q2 EPS USD 0.85 Vs. IBES Estimate USD 0.86 Sep 26 (Reuters) - Carmax Q2 gross profit USD 760.5 million. Q2 revenue USD 2,000 million vs. IBES estimate USD 6,786 million
C

Micron adds fresh tech fizz, China surges anew

MORNING BID AMERICAS-Micron adds fresh tech fizz, China surges anew A look at the day ahead in U.S. and global markets from Mike Dolan With quarter-end fast approaching, tech excitement returned to Wall Street overnight with another AI-driven earnings beat from Micron Technology MU.O , while China's stocks .CSI300 surged anew after this week's monetary easing blitz.
C
C
M
U
J
U
U
U
C

U.S. Cardinal Health, Factset, Paylocity

U.S. RESEARCH ROUNDUP-Cardinal Health, Factset, Paylocity Sept 23 (Reuters) - .Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cardinal Health, Factset and Paylocity Holding on Monday. HIGHLIGHTS * Cardinal Health Inc CAH.N : Baird raises target price to $140 from $137 * Factset FDS.N : Jefferies raises target price to $486 from $435 * Marinus Pharmaceuticals Inc MRNS.O : Oppenheimer raises to outperform from perform * Paylocity
B
P
V
A
P
C
D
L
L
U

U.S. earnings week ahead

DIARY-U.S. earnings week ahead Sept 20 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 24-Sep-2024 BMO AZO Autozone Inc Q4 2024 Autozone Inc Earnings Release 25-Sep-2024 AMC MU.O Micron Technology Inc Q4 2024 Micron Technology Inc Earnings Release 25-Sep-2024 BMO CTAS.O Cintas Corp Q1 2025 Cintas Corp Earnings Release 26-Sep-2024 AMC
C
C
M
U
C

U.S. Athira Pharma, Lowe's Companies, P&G

U.S. RESEARCH ROUNDUP-Athira Pharma, Lowe's Companies, P&G Sept 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Athira Pharma, Lowe's Companies and P&G on Thursday. HIGHLIGHTS * Athira Pharma Inc ATHA.O : Mizuho cuts to neutral from outperform * Five Below Inc FIVE.O : JP Morgan cuts to underweight from neutral * Lowe's Companies Inc LOW.N : TD Cowen raises target price to $265 from $240 * P&G PG.N : JP Morgan rai
A
A
C
D
M
N
T
A
C

U.S. Autozone, Costco Wholesale, Walmart

U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Walmart Sept 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autozone, Costco Wholesale and Walmart, on Wednesday. HIGHLIGHTS * Autozone Inc AZO.N : Evercore ISI raises target price to $3900 from $3350 * Costco Wholesale Corp COST.O : Evercore ISI raises target price to $985 from $925 * Home Depot Inc HD.N : Evercore ISI raises target price to $420 from $400 * Tra
B
C
C
C
F
K
N
D
E
T
S
A
C
G



Syarat

Aset Popular

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.